Data protection Impressum

Life sciences

EP Equity Investment (EPEI), a company dedicated to investing in promising European companies, has acquired a 24.99% stake in Nanobacterie to advance the development of innovative treatments for prostate cancer.

Nanobacterie secures strategic investment from EP Equity to advance prostate cancer treatment

6 May 2024

Takeda Pharmaceutical has announced a CHF 5 million investment in renewable energy for its Neuchâtel facility.

Takeda commits CHF 5 million to renewable energy for its Neuchâtel site

29 April 2024

Risklick, a spin-off from the University of Bern, has unveiled its cutting-edge software, Protocol AI, designed to transform the landscape of pharmaceutical development.

UniBe spin-off Risklick unveils AI tool to streamline clinical trials

29 April 2024

Researchers at the EPFL have engineered lab-grown mini-colons that replicate the development of colorectal tumors with high fidelity.

EPFL scientists create lab-grown mini-colons to advance colorectal cancer research

29 April 2024

The latest edition of the Swiss Biotech Report underscores the continued growth and resilience of Switzerland’s biotech sector, attributing success to strong international collaborations and innovative advancements that promise to reshape healthcare worldwide.

The Swiss biotech industry: reliable partners beyond borders

23 April 2024

Isospec Analytics, a Vaud-based start-up specializing in biomolecular analysis, has secured USD 1.9 million in pre-seed funding to advance its revolutionary diagnostic technologies.

Isospec pioneers rapid diagnostic technologies with USD 1.9 million funding

22 April 2024

This initiative reflects a broader shift towards life sciences, driven by innovation and a commitment to health, wellness, and sustainability.

The HES-SO strengthens life sciences education and research in the canton of Valais

22 April 2024

Vaud-based biopharma Oculis has secured USD 59 million to extend operations into 2026, following a successful listing on NASDAQ Iceland Main Market.

Oculis announces completion of oversubscribed USD 59 million registered direct offering

15 April 2024

Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment through 3D printing.

Swibrace advances to clinical phase with innovative 3D-printed wrist braces

15 April 2024

With CHF 7.75 million from the BRH Foundation, the University of Bern and Insel Gruppe have launched a professorship to innovate in rehabilitation.

University of Bern introduces endowed professorship in interdisciplinary rehabilitation

15 April 2024

1 … 8 9 10 11 12 13 14 15 16 … 42